RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?

by Jonas B. Sandbrink, Robin J. Shattock
Published 2020-12-01

Which topical microbicides for blocking HIV-1 transmission will work in the real world?

by Per Johan Klasse, Robin J Shattock, John P Moore
Published 2006-09-01

Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice.

by Viviana Buffa, Katja Klein, Lucia Fischetti, Robin J Shattock
Published 2012-01-01

Structural Components for Amplification of Positive and Negative Strand VEEV Splitzicons

by Anna K. Blakney, Paul F. McKay, Robin J. Shattock
Published 2018-07-01

A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in mice.

by John S Tregoning, Viviana Buffa, Anna Oszmiana, Katja Klein, Adam A Walters, Robin J Shattock
Published 2013-01-01

Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.

by Deborah F L King, Paul F McKay, Jamie F S Mann, C Bryn Jones, Robin J Shattock
Published 2015-01-01

Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice.

by Jamie F S Mann, Paul F McKay, Samantha Arokiasamy, Reeyeshkumar K Patel, John S Tregoning, Robin J Shattock
Published 2013-01-01

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs

by Carolina Herrera, Mike D. McRaven, Ken G. Laing, Jayne Dennis, Thomas J. Hope, Robin J. Shattock
Published 2021-03-01

TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.

by Paul F McKay, Deborah F L King, Jamie F S Mann, Guillermo Barinaga, Darrick Carter, Robin J Shattock
Published 2016-01-01

Improving defences at the portal of HIV entry: mucosal and innate immunity.

by Robin J Shattock, Barton F Haynes, Bali Pulendran, Jorge Flores, José Esparza, Working Group convened by the Global HIV Vaccine Enterprise
Published 2008-04-01

A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.

by Frank Wegmann, George Krashias, Kerstin Lühn, Karoliina Laamanen, Sueli Vieira, Simon A Jeffs, Robin J Shattock, Quentin J Sattentau
Published 2011-01-01

Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions

by Anush Arakelyan, Wendy Fitzgerald, Deborah F. King, Paul Rogers, Hannah M. Cheeseman, Jean-Charles Grivel, Robin J. Shattock, Leonid Margolis
Published 2017-04-01

HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo.

by Melanie Merbah, Anush Arakelyan, Tara Edmonds, Christina Ochsenbauer, John C Kappes, Robin J Shattock, Jean-Charles Grivel, Leonid B Margolis
Published 2012-01-01

Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans

by Jenna Anderson, Thorunn A. Olafsdottir, Sven Kratochvil, Paul F. McKay, Malin Östensson, Josefine Persson, Robin J. Shattock, Ali M. Harandi
Published 2018-02-01

Optimisation of ex vivo memory B cell expansion/differentiation for interrogation of rare peripheral memory B cell subset responses [version 2; referees: 2 approved]

by Luke Muir, Paul F. McKay, Velislava N. Petrova, Oleksiy V. Klymenko, Sven Kratochvil, Christopher L. Pinder, Paul Kellam, Robin J. Shattock
Published 2018-01-01

Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination

by Sven Kratochvil, Paul F. McKay, Amy W. Chung, Stephen J. Kent, Stephen J. Kent, Stephen J. Kent, Jill Gilmour, Robin J. Shattock
Published 2017-12-01

Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.

by Alexander Badamchi-Zadeh, Paul F McKay, Martin J Holland, Wayne Paes, Andrzej Brzozowski, Charles Lacey, Frank Follmann, John S Tregoning, Robin J Shattock
Published 2015-01-01

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination

by Sven Kratochvil, Paul F. McKay, Amy W. Chung, Stephen J. Kent, Stephen J. Kent, Stephen J. Kent, Jill Gilmour, Robin J. Shattock
Published 2018-02-01

Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.

by Hannah M Cheeseman, Ann M Carias, Abbey B Evans, Natalia J Olejniczak, Paul Ziprin, Deborah F L King, Thomas J Hope, Robin J Shattock
Published 2016-01-01

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.

by Mauricio A Arias, Griet A Van Roey, John S Tregoning, Magdalini Moutaftsi, Rhea N Coler, Hillarie P Windish, Steven G Reed, Darrick Carter, Robin J Shattock
Published 2012-01-01